Targeting ROS for Cancer Therapy

Jingwu Dong¹, Bin Liu^2,3 and Runzhi Zhu^1,2,4*

¹Clinical Research Center, Xuyi People’s Hospital, Xuyi 211700, PR China

²Key Laboratory of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang Key Laboratory of Hepatobiliary Diseases, Zhanjiang 524001, PR China

³Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, PR China

⁴Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA

^*Corresponding Author: Prof. Runzhi Zhu, Clinical Research Center of Xuyi People’s Hospital, 28 Hongwu Road Xuyi Economic Development District, Xuyi, Jiangsu 211700, PR China, Tel: +86 138-5166-1148 Email: